Michele Caraglia
Michele Caraglia
Professore Ordinario di Biochimica, UniversitÓ della Campania "L. Vanvitelli", Dipartimento di
Verified email at unicampania.it - Homepage
TitleCited byYear
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
8379*2016
Mir-34: a new weapon against cancer?
G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ...
Molecular Therapy-Nucleic Acids 3, e195, 2014
3582014
Familial papillary thyroid microcarcinoma: a new clinical entity
G Lupoli, G Vitale, M Caraglia, MR Fittipaldi, A Abbruzzese, P Tagliaferri, ...
The Lancet 353 (9153), 637-639, 1999
1991999
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
M Marra, IM Sordelli, A Lombardi, M Lamberti, L Tarantino, A Giudice, ...
Journal of translational medicine 9 (1), 171, 2011
1932011
Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels iná…
D Santini, B Vincenzi, S Galluzzo, F Battistoni, L Rocci, O Venditti, ...
Clinical Cancer Research 13 (15), 4482-4486, 2007
1922007
Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence
MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ...
Clinical cancer research 18 (22), 6260-6270, 2012
1852012
The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis
A Lamberti, M Caraglia, O Longo, M Marra, A Abbruzzese, P Arcari
Amino acids 26 (4), 443-448, 2004
1792004
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib
B Vincenzi, D Santini, A Russo, R Addeo, F Giuliani, L Montella, S Rizzo, ...
The oncologist 15 (1), 85, 2010
1762010
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro
P Tassone, P Tagliaferri, C Viscomi, C Palmieri, M Caraglia, ...
British journal of cancer 88 (12), 1971-1978, 2003
1762003
Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, iná…
E Di Gennaro, M Barbarino, F Bruzzese, S De Lorenzo, M Caraglia, ...
Journal of cellular physiology 195 (1), 139-150, 2003
1702003
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
M Donadelli, I Dando, T Zaniboni, C Costanzo, E Dalla Pozza, MT Scupoli, ...
Cell death & disease 2 (4), e152-e152, 2011
1652011
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra, B Vincenzi, G Tonini, A Budillon
Endocrine-related cancer 13 (1), 7-26, 2006
1482006
miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease
M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ...
Journal of cellular physiology 228 (7), 1506-1515, 2013
1472013
Alpha‐interferon and its effects on signal transduction pathways
M Caraglia, M Marra, G Pelaia, R Maselli, M Caputi, SA Marsico, ...
Journal of cellular physiology 202 (2), 323-335, 2005
1462005
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine
M Donadelli, C Costanzo, S Beghelli, MT Scupoli, M Dandrea, A Bonora, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (7), 1095-1106, 2007
1442007
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ...
Cell death & disease 3 (11), e436-e436, 2012
1432012
Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi‐chaperone complex in human epidermoid cancer cells
M Caraglia, M Marra, F Mancinelli, G D'ambrosio, R Massa, A Giordano, ...
Journal of cellular physiology 204 (2), 539-548, 2005
1412005
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
N Amodio, M Leotta, D Bellizzi, MT Di Martino, P D'Aquila, M Lionetti, ...
Oncotarget 3 (10), 1246, 2012
1292012
Current approaches and perspectives in the therapy of medullary thyroid carcinoma
G Vitale, M Caraglia, A Ciccarelli, G Lupoli, A Abbruzzese, P Tagliaferri, ...
Cancer: Interdisciplinary International Journal of the American Cancerá…, 2001
1272001
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
F Bruzzese, A Leone, M Rocco, C Carbone, G Piro, M Caraglia, ...
Journal of cellular physiology 226 (9), 2378-2390, 2011
1192011
The system can't perform the operation now. Try again later.
Articles 1–20